BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fierro J, Dipasquale J, Perez J, Chin B, Chokpapone Y, Tran AM, Holden A, Factoriza C, Sivagnanakumar N, Aguilar R, Mazal S, Lopez M, Dou H. Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-06430-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Z, Gao D, Zhao J, Yang G, Guo M, Wang Y, Ren X, Kim JS, Jin L, Tian Z, Zhang X. Thermal immuno-nanomedicine in cancer. Nat Rev Clin Oncol 2023;20:116-34. [PMID: 36604531 DOI: 10.1038/s41571-022-00717-y] [Reference Citation Analysis]
2 McGrail M, Sakuma T, Bleris L. Genome editing. Sci Rep 2022;12:20497. [PMID: 36443399 DOI: 10.1038/s41598-022-24850-x] [Reference Citation Analysis]
3 Xu C, Xiao M, Li X, Xin L, Song J, Zhan Q, Wang C, Zhang Q, Yuan X, Tan Y, Fang C. Origin, activation, and targeted therapy of glioma-associated macrophages. Front Immunol 2022;13:974996. [DOI: 10.3389/fimmu.2022.974996] [Reference Citation Analysis]
4 Ji H, Liu Z, Wang F, Sun H, Wang N, Liu Y, Hu S, You C. Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction. Front Immunol 2022;13:941556. [DOI: 10.3389/fimmu.2022.941556] [Reference Citation Analysis]